Application no. and date | 18214711.6 (espacenet) (Federated) (European Patent Register), 20141113 | Patent/reg. no. and date | DK/EP 3492593, 20210818 | Publication date | 20190605 | Priority no. and date | US 201361903823 P, 20131113, US 201462042075 P, 20140826 | EP pub. no. and date |
EP 3492593 20190605 | Effective date | | Applicant/owner | Children's Medical Center Corporation, 55 Shattuck Street
Boston, MA 02115, US, Sangamo Therapeutics, Inc., 7000 Marina Blvd
Brisbane, CA 94005, US | Applicant ref. no. | 1605801 | Inventor | ORKIN, Stuart H., c/o Children's Medical Center Corporation 55 Shattuck Street
Boston, MA Massachusetts 02115, US, REIK, Andreas, c/o Sangamo Therapeutics, Inc. 7000 Marina Blvd
Brisbane CA 94005, US, URNOV, Fyodor, c/o Sangamo Therapeutics, Inc. 7000 Marina Blvd
Brisbane CA 94005, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 35/12 (2015.01) , A61K 35/28 (2015.01) , A61K 38/46 (2006.01) , A61P 7/00 (2006.01) , C07K 14/47 (2006.01) , C12N 15/09 (2006.01) , C12N 15/113 (2010.01) , C12N 9/22 (2006.01) | Title | NUKLEASEMEDIERET REGULERING AF GENEKSPRESSION | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|